2000
DOI: 10.1378/chest.117.3.902
|View full text |Cite
|
Sign up to set email alerts
|

Conservative Treatment of Postsurgical Lymphatic Leaks With Somatostatin-14

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
66
0
9

Year Published

2002
2002
2016
2016

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 119 publications
(75 citation statements)
references
References 15 publications
0
66
0
9
Order By: Relevance
“…They could also respond to somastostatin therapy. 9 Somastostatin was not used in our case as it can cause hypotension and our patient presented with hypotension and electrolyte imbalance. However, a somatostatin analogue, Octreotide is the agent most commonly employed, beginning with a dose of 50 mcg thrice a day (TID) given subcutaneously, upto a maximum of 200 mcg TID.…”
Section: Discussionmentioning
confidence: 88%
“…They could also respond to somastostatin therapy. 9 Somastostatin was not used in our case as it can cause hypotension and our patient presented with hypotension and electrolyte imbalance. However, a somatostatin analogue, Octreotide is the agent most commonly employed, beginning with a dose of 50 mcg thrice a day (TID) given subcutaneously, upto a maximum of 200 mcg TID.…”
Section: Discussionmentioning
confidence: 88%
“…Initial experience with continuous intravenous high-dose somatostatin for closure of postoperative lymphorrhagia was reported in 1990 by Ulibarri et al[ 26], satisfactory results were also achieved by others [22,23,24,25]. The exact mechanism involved in the claimed favorable effect of somatostatin is not completely understood.…”
Section: Discussion (Table 1)mentioning
confidence: 99%
“…The exact mechanism involved in the claimed favorable effect of somatostatin is not completely understood. It has been previously shown to decrease the intestinal absorption of fats, to lower triglyceride concentration in the thoracic duct and to attenuate lymph flow in the major lymphatic channels [23]. In addition, it also decreases gastric, pancreatic and intestinal secretions, inhibits motor activity of the intestine, slows the process of intestinal absorption and decreases splanchnic blood flow, which further contributes to decrease lymph production [25].…”
Section: Discussion (Table 1)mentioning
confidence: 99%
“…Ha a drénvezetés jelentősen csökken konzervatív kezelés hatására, javasolt a terápia állandósítása néhány hé-tig fenntartott szigorú MCT-vagy zöldség-gyümölcs diéta mellett [22,48,49].…”
Section: áBraunclassified
“…Ugyanakkor a pleurodesis csak teljesen kitágulni képes tüdővel rendelkező betegeknél lehet sikeres (úgynevezett non-trapped tüdő esetén) [32]. A pleurodesis sikerrátája 71-100% közötti (2. táblázat), de 15%-os komplikációs rátával kell szá-molni [34,49].…”
Section: Intervenciós Kezelésunclassified